The CCL22-CCR4 axis, which recruits Tregs to foster immunosuppression and chemoresistance in ESCA, also enriches Tregs in NSCLC and CRC, contributing to ICI resistance. The gene discussed is CCL22; the disease is non-small cell lung carcinoma.